Live Breaking News & Updates on Coherus Biosciences Daily
Stay updated with breaking news from Coherus biosciences daily. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
HC Wainwright reissued their buy rating on shares of Coherus BioSciences (NASDAQ:CHRS – Free Report) in a research report sent to investors on Friday, Benzinga reports. The brokerage currently has a $12.00 price target on the biotechnology company’s stock. Separately, Truist Financial cut their price target on shares of Coherus BioSciences from $8.00 to $7.00 […] ....
Coherus BioSciences (NASDAQ:CHRS) Receives Buy Rating from HC Wainwright theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
14,020 Shares in Coherus BioSciences, Inc. (NASDAQ:CHRS) Purchased by Baader Bank Aktiengesellschaft wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.
Coherus BioSciences, Inc. (NASDAQ:CHRS) Receives Consensus Recommendation of "Moderate Buy" from Analysts dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.
Coherus BioSciences (CHRS) to Release Earnings on Thursday themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.